-
1
-
-
0034303612
-
Neuronal KCNQ potassium channels: Physiology and role in disease
-
Jentsch TJ: Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 2000; 1:21-30.
-
(2000)
Nat Rev Neurosci
, vol.1
, pp. 21-30
-
-
Jentsch, T.J.1
-
2
-
-
0035425653
-
Activation of expressed KCNQ potassium currents and native neurona l M-t y pe potassium currents by the anti-convulsant drug retigabine
-
Tatulian L, Delmas P, Abogadie FC, Brown DA: Activation of expressed KCNQ potassium currents and native neurona l M-t y pe potassium currents by the anti-convulsant drug retigabine. J Neurosci 2001; 21: 5535-5545.
-
(2001)
J Neurosci
, vol.21
, pp. 5535-5545
-
-
Tatulian, L.1
Delmas, P.2
Abogadie, F.C.3
Brown, D.A.4
-
3
-
-
0035122602
-
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
-
Wickenden AD, Zou A, Wagoner PK, Jegla T: Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. Br J Pharmacol 2001; 132: 381-38 4.
-
(2001)
Br J Pharmacol
, vol.132
, pp. 381-384
-
-
Wickenden, A.D.1
Zou, A.2
Wagoner, P.K.3
Jegla, T.4
-
4
-
-
15744400656
-
The new anticonvulsant retiga-bine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate
-
Wuttke T V, Seebohm G, Bail S, Maljevic S, Lerche H: The new anticonvulsant retiga-bine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 2005; 67: 1009-1017.
-
(2005)
Mol Pharmacol
, vol.67
, pp. 1009-1017
-
-
Wuttke, T.V.1
Seebohm, G.2
Bail, S.3
Maljevic, S.4
Lerche, H.5
-
6
-
-
33750614291
-
The acryl-amide (S)-1 differentially affects Kv7 (KCNQ) potassium channels
-
Bentzen BH, Schmitt N, Calloe K, Dalby-Brown W, Grunnet M, Olesen SP: The acryl-amide (S)-1 differentially affects Kv7 (KCNQ) potassium channels. Neurophar-macolog y 2006; 51: 106 8-1077.
-
(2006)
Neurophar-macolog y
, vol.51
, pp. 1068-1077
-
-
Bentzen, B.H.1
Schmitt, N.2
Calloe, K.3
Dalby-Brown, W.4
Grunnet, M.5
Olesen, S.P.6
-
7
-
-
40849085408
-
N-(6-Chloro-pyridin-3-yl)-3,4-dif luoro-benza-mide (ICA-27243): A novel, selective KCNQ2/Q3 potassium channel activator
-
Wickenden AD, Krajewski JL, London B, Wagoner PK, Wilson WA, Clark S, Roeloffs R, Naughton-Smith G, Rigdon GC: N-(6-Chloro-pyridin-3-yl)-3,4-dif luoro-benza-mide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol Pharmacol 2008; 73: 977-986.
-
(2008)
Mol Pharmacol
, vol.73
, pp. 977-986
-
-
Wickenden, A.D.1
Krajewski, J.L.2
London, B.3
Wagoner, P.K.4
Wilson, W.A.5
Clark, S.6
Roeloffs, R.7
Naughton-Smith, G.8
Rigdon, G.C.9
-
8
-
-
0033916576
-
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine
-
Main MJ, Cryan JE, Dupere JRB, Cox B, Clare JJ, Burbidge SA: Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 2000; 58: 253-262.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 253-262
-
-
Main, M.J.1
Cryan, J.E.2
Jrb, D.3
Cox, B.4
Clare, J.J.5
Burbidge, S.A.6
-
9
-
-
70349329230
-
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site
-
Padilla K, Wickenden AD, Gerlach AC, Mc-Cormack K: The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site. Neurosci Lett 2009; 465: 138-142.
-
(2009)
Neurosci Lett
, vol.465
, pp. 138-142
-
-
Padilla, K.1
Wickenden, A.D.2
Gerlach, A.C.3
Mc-Cormack, K.4
-
10
-
-
43349097329
-
V 7 (KCNQ) channel modulators: An update
-
V 7 (KCNQ) channel modulators: an update. Expert Opin Ther Tar 2008; 12: 565-581.
-
(2008)
Expert Opin Ther Tar
, vol.12
, pp. 565-581
-
-
Gribkoff, V.K.1
-
12
-
-
42949111169
-
Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers
-
Xiong Q, Sun H, Zhang Y, Nan F, Li M: Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers. Proc Natl Acad Sci USA 2008; 105: 312 8-3133.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 3128-3133
-
-
Xiong, Q.1
Sun, H.2
Zhang, Y.3
Nan, F.4
Li, M.5
-
13
-
-
33747618030
-
The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat
-
Hansen HH, Ebbesen C, Mathiesen C, Wei-kop P, Ronn LC, Waroux O, Scuvee-Moreau J, Seutin V, Mikkelsen JD: The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J Pharmacol Exp Ther 2006; 318:1006-1019.
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 1006-1019
-
-
Hansen, H.H.1
Ebbesen, C.2
Mathiesen, C.3
Wei-Kop, P.4
Ronn, L.C.5
Waroux, O.6
Scuvee-Moreau, J.7
Seutin, V.8
Mikkelsen, J.D.9
-
14
-
-
34547841517
-
The neu-ronal KCNQ channel opener retigabine inhibits locomotor activity and reduces fore-brain excitatory responses to the psycho-stimulants cocaine, methylphenidate and phencyclidine
-
Hansen HH, Andreasen JT, Weikop P, Mirza N, Scheel-Kruger J, Mikkelsen JD: The neu-ronal KCNQ channel opener retigabine inhibits locomotor activity and reduces fore-brain excitatory responses to the psycho-stimulants cocaine, methylphenidate and phencyclidine. Eur J Pharmacol 2007; 570: 77-88.
-
(2007)
Eur J Pharmacol
, vol.570
, pp. 77-88
-
-
Hansen, H.H.1
Andreasen, J.T.2
Weikop, P.3
Mirza, N.4
Scheel-Kruger, J.5
Mikkelsen, J.D.6
-
15
-
-
62449333567
-
Anti-psychotic-like effect of retigabine [N-(2-amino-4- [fluorobenzylamino]-phenyl)car-bamic acid ester], a KCNQ potassium channel opener, via modulation of meso-limbic dopaminergic neurotransmission
-
Sotty F, Damgaard T, Montezinho LP, Mork A, Olsen CK, Bundgaard C, Husum H: Anti-psychotic-like effect of retigabine [N-(2-amino-4-[fluorobenzylamino]- phenyl)car-bamic acid ester], a KCNQ potassium channel opener, via modulation of meso-limbic dopaminergic neurotransmission. J Pha rmacol Exp Ther 2009; 32 8: 951-9 62.
-
(2009)
J Pha Rmacol Exp Ther
, vol.328
, pp. 951-962
-
-
Sotty, F.1
Damgaard, T.2
Montezinho, L.P.3
Mork, A.4
Olsen, C.K.5
Bundgaard, C.6
Husum, H.7
|